Clinical Trials Browser

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03301350 2026-02-13

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Phase 2 Completed

29 enrolled 15 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07367178 2026-01-28

SATROPIN

Phase 2 Not yet recruiting

30 enrolled

Breast

Breast Neoplasms

NCT05520723 2025-12-04

PRIMED

Phase 2 Completed

50 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast

Breast Neoplasms

NCT00074269 2023-06-05

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Phase 2 Terminated

5 enrolled 10 charts

Breast

Breast Neoplasms

NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Phase 2 Terminated

22 enrolled

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

Phase 2 Completed

39 enrolled 16 charts

Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2 Completed

68 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Phase 2 Completed

50 enrolled 13 charts

Breast

Breast Neoplasms

NCT00407888 2017-08-31

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Phase 2 Completed

60 enrolled 11 charts

Breast

Breast Neoplasms

NCT01569087 2016-12-05

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Phase 2 Completed

60 enrolled 17 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02225652 2014-08-26

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Phase 2 Completed

11 enrolled

Breast

Women With Primary Breast Cancer

NCT00119262 2014-05-15

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Phase 2 Completed

226 enrolled 8 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Phase 2 Unknown

Breast

Breast Neoplasms

NCT00002680 2013-07-24

Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

Phase 2 Completed

40 enrolled

Breast

Breast Neoplasms

NCT00020176 2013-06-20

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00041067 2013-06-06

S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Phase 2 Completed

76 enrolled 6 charts

Breast

Breast Neoplasms

NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Phase 2 Completed

62 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00004900 2013-05-30

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms

NCT00004906 2013-05-30

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms

NCT00072319 2013-03-04

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003953 2013-01-28

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase 2 Completed

39 enrolled

Breast

Breast Neoplasms

NCT00001832 2012-12-21

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Phase 2 Completed

170 enrolled 23 charts

BreastDermatologic

Breast Neoplasms, Melanoma, Neoplasm Metastasis

NCT00007904 2012-10-02

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Phase 2 Completed

16 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Phase 2 Completed

45 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00004172 2012-06-12

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms

NCT00003392 2012-02-22

High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

Phase 2 Completed

61 enrolled

Breast

Breast Neoplasms

NCT00771433 2011-05-13

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Phase 2 Completed

120 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT00003035 2011-03-24

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Phase 2 Completed

40 enrolled

Breast

Breast Neoplasms

NCT00002679 2009-08-26

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

Phase 2 Completed

89 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00194740 2007-12-06

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

Phase 2 Completed

48 enrolled

Breast

Breast Neoplasms

Clinical Trials

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

SATROPIN

PRIMED

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

A Study of LY2523355 in Participants With Breast Cancer

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer